explore -WSS

explore

author：explore 2025-09-30 22:05:58 - browse：79153

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： See how much Covid

focus

WSS

What to know about Virgin Galactic's 1st mission taking paying customers to space

Police still searching for prisoner who escaped from NYC hospital

How to increase colonoscopy rates? Looks like an AI can help

Naloxone nonprofit donates 200,000 doses after FDA approval

Drastic changes should bring profitability, startup health insurers say

How to increase colonoscopy rates? Looks like an AI can help

leisure time

explore

knowledge

New air purifier tech could be key to improving indoor air quality

Ultragenyx gene therapy for rare liver ailment succeeds in late

BioMarin wins approval for gene therapy to treat hemophilia A

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Heart attack and stroke risk calculators need revising

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Guidelines to prevent youth baseball injuries need more muscle

At ASCO, AstraZeneca reports strong data for breast cancer drug

Medical leaders decry Supreme Court decision on affirmative action

Change Healthcare can notify patients about the breach, HHS says

hotspot

What to know about Virgin Galactic's 1st mission taking paying customers to space

With trial win, GSK could get blood cancer drug back on market

ASCO: AstraZeneca says CAR

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

BMI, flaws aside, is found to be useful estimate of body fat in youth

Police still searching for prisoner who escaped from NYC hospital

entertainment

hotspot

focus

leisure time